Compared with controls, the numbers of STING+/CCR2+ and STING+/S100A9+ macrophages in the livers of NASH patients are increased significantly, and they are positively correlated with the liver inflammation grade and fibrosis stage (Wang et al., 2020). The gene discussed is STING1; the disease is metabolic dysfunction-associated steatohepatitis.